AZTR news & sentiment — Azitra, Inc.

MAY 13·MinichartMed

Azitra, Inc. Announces Q1 2026 Financial Results and Pipeline Milestones for Biotherapeutics and Cosmeceuticals

Azitra, Inc. (NYSEAMER: AZTR) announced its Q1 2026 financial results, reporting increased R&D expenses and a net loss of $3.93 million, but also a significant increase in cash and stockholder's equity. The company is continuing IND-enabling studies for its product candidates and noted a substantial increase in weighted average shares outstanding, suggesting recent capital raises. Investors are advised to monitor progress on studies and capital management due to potential share price impact.

MAR 20·Stocktwits

Why Is AZTR Stock Rising Today?

Azitra Inc. (AZTR) shares surged over 80% after the biopharmaceutical firm announced a private placement to raise more than $31 million. This rally comes days after the company received a listing warning from NYSE American LLC for failing to meet minimum stockholders' equity requirements. The funding will be used to advance new protein and peptide research programs for skincare solutions, despite the company reporting widening net losses.

AUG 22·Benzinga

Why Azitra Stock Shot Up 59% After-Hours? - Azitra ( AMEX:AZTR )

Azitra Inc. AZTR shares skyrocketed 58.71% in after-hours trading to $1.51 on Thursday, following the implementation of a 1-for-6.66 reverse stock split and significant SEC filing activity that revealed new institutional ownership. Check out the current price of AZTR stock here.

$AZTR

Azitra, Inc. Announces Q1 2026 Financial Results and Pipeline Milestones for Biotherapeutics and Cosmeceuticals

Why Is AZTR Stock Rising Today?

Why Azitra Stock Shot Up 59% After-Hours? - Azitra ( AMEX:AZTR )

News on $AZTR